Randomized Controlled Study of Plasma ctDNA Methylation-Guided Adjuvant Chemotherapy in Stage I/Low-Risk Stage II Colorectal Cancer

NCT07562659 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

ctDNA
Colorectal Cancer (CRC)
Adjuvant Chemotherapy

Interventions

DRUG: Capecitabine

Sponsor

Fudan University